Male circumcision has been shown to reduce the risk of acquiring and transmitting a number of venereal infections. However, little is known about the association between male circumcision and the risk of Chlamydia trachomatis infection in the female partner. The authors pooled data on 305 adult couples enrolled as controls in one of five case-control studies of invasive cervical cancer conducted in Thailand, the Philippines, Brazil, Colombia, and Spain between 1985 and 1997. Women provided blood samples for C. trachomatis and Chlamydia pneumoniae antibody detection; a type-specific microfluorescence assay was used. Multivariate odds ratios were computed for the association between male circumcision status and chlamydial seropositivity in women. Compared with women with uncircumcised partners, those with circumcised partners had a 5.6-fold reduced risk of testing seropositive for C. trachomatis (82% reduction; odds ratio ¼ 0.18, 95% confidence interval: 0.05, 0.58). The inverse association was also observed after restricting the analysis to monogamous women and their only male partners (odds ratio ¼ 0.21, 95% confidence interval: 0.06, 0.72). In contrast, seropositivity to C. pneumoniae, a non-sexually-transmitted infection, was not significantly related to circumcision status of the male partner. These findings suggest that male circumcision could reduce the risk of C. trachomatis infection in female sexual partners.
infections in the United States, responsible for an estimated 3 million new infections each year and a total annual cost of $2 billion for care (1) .
Clinical manifestations of C. trachomatis infections in women include acute urethral syndrome, urethritis, bartholinitis, cervicitis, upper genital tract infection, perihepatitis, and reactive arthritis (1) . Genital C. trachomatis infections have been clinically associated with cytologic cervical atypia and induction of cervical metaplasia (2) , and they have been considered a likely human papillomavirus (HPV) cofactor that increases the risk of cervical cancer (3, 4) . Untreated chlamydial infection can lead to severe reproductive complications being an important causal agent in pelvic inflammatory disease that can lead to infertility, ectopic pregnancy, and chronic pelvic pain (5) .
In men, the most common clinical manifestation is nongonococcal urethritis, causing approximately 35-50 percent of all cases of nongonococcal urethritis in heterosexual men. Other clinical syndromes in men include acute epididymitis, acute proctitis, acute proctocolitis, conjunctivitis, and Reiter's syndrome (1) . Male infertility, chronic prostatitis, and urethral strictures are possible results of infection. Infection with C. trachomatis is also believed to be a cofactor for transmission of human immunodeficiency virus in both men and women (6) .
Evidence from several studies suggests that male circumcision may reduce the risk of acquiring and transmitting a number of venereal diseases, including human immunodeficiency virus (7, 8) . However, the few reports looking at the association between male circumcision and C. trachomatis infections in men have yielded inconsistent results (9) (10) (11) (12) (13) (14) (15) . To our knowledge, the possible relation between male circumcision and C. trachomatis infection in the female partner has never been explored.
We previously reported on a negative association between male circumcision and penile HPV DNA detection and, in men with multiple female sexual partners, on a reduced risk of developing cervical cancer in their spouses (16) . In this report, we analyze data from a subset of couples who participated as controls in an international multicenter case-control study of invasive cervical cancer (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . The aim of this study was to explore the association between circumcision status and the risk of C. trachomatis infection in female sexual partners as assessed by type-specific serologic assays, using as a validity control serodetection of antibodies against Chlamydia pneumoniae, a non-sexually-transmitted infection.
MATERIALS AND METHODS

Study design
Study subjects for these analyses were the controls enrolled in an international, multicenter case-control study of invasive cervical cancer conducted in Colombia (23, 25) , Spain (18) , Brazil (21) , Thailand (20) , and the Philippines (26) between 1985 and 1997. The study was coordinated by the International Agency for Research on Cancer. Each study used a similar protocol and questionnaire for recruitment and data collection. Details of the methods of each study have been published previously (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . In brief, women controls for the case-control studies were recruited from the general population in Spain and Colombia and from the same hospitals as the women cases for the other studies. In all studies, women controls were frequency matched to the cases with invasive cervical cancer according to age. Men eligible for the present study were the husbands or stable partners of the women controls enrolled in each of the case-control studies. A man was considered a stable partner of an enrolled woman if he reported having had regular sexual intercourse with the woman for at least 6 months, whether or not they were married or lived together. Selection of the final study couples included in this analysis was driven by the availability of sera and of information on circumcision status.
All protocols were approved by the International Agency for Research on Cancer and the local ethics and research committees. Informed consent was obtained from all study subjects. Human experimentation guidelines of the International Agency for Research on Cancer and those of the participating institutions in Colombia, Spain, Brazil, the Philippines, and Thailand were rigorously followed.
Questionnaire and medical examination
Subjects were interviewed and information was collected on demographic and socioeconomic variables, sexual history, and circumcision status by use of a standardized questionnaire. As reported previously, self-reported circumcision status was assessed by a clinician for 97.4 percent of the men recruited in the studies in Brazil, Thailand, and the Philippines (16) . Since the reliability between the two measures was very high (kappa ¼ 0.89), self-reported circumcision status was used for the current analyses.
Detection of C. trachomatis antibodies
The strategy used for Chlamydia antibody detection in women was identical to that used in two previous reports of the same study population (3, 4) . Briefly, C. trachomatis immunoglobulin G antibodies were determined by a microimmunofluorescence (MIF) assay (28) , considered the reference standard for chlamydial serology. MIF assays were conducted blinded to the partner's circumcision status. The antigen panel consisted of purified elementary bodies of C. trachomatis (serovar A and three pooled serovar groups of BDE, CJHI, and FGK) and C. pneumoniae, which was included to monitor cross-reactive, genus-specific antibody responses against all chlamydial species. Sera were screened for C. trachomatis at 1:8 dilution and titered to endpoint (1:8, 1:32, 1:128, >1:128). An immunoglobulin G titer of 1:8 against any C. trachomatis serovar group was considered evidence of past C. trachomatis infection. An immunoglobulin G titer of 1:16 against C. pneumoniae was considered evidence of past C. pneumoniae respiratory infections.
As reported previously, from the biologic bank of the international study, sera with identical titers for all C. trachomatis and C. pneumoniae species were also tested against Chlamydia psittaci (avian strain 6BC) to determine the presence of genus-specific antibody responses (3, 4) . Sera from six cases and 11 controls with identical titers for C. trachomatis, C. pneumoniae, and C. psittaci, and from 20 cases and 23 controls who were seropositive for serovar A and negative for all other C. trachomatis serovars, were considered noninformative as to C. trachomatis serologic status and were not included in the analyses. Sera from subjects in Spain and Colombia that had already been evaluated by using a simplified MIF assay based on the L2 serovar were retested by using the MIF assay described above to improve the specificity of previous findings. Furthermore, a blinded reproducibility study based on the overall study sera was conducted by retesting a random sample of 222 specimens (9.5 percent) twice (4). Percent agreement for C. trachomatis serovars A, BDE, CJHI, and FGK and for C. pneumoniae was 85.3 percent, 86.2 percent, 86.7 percent, and 84.9 percent, and 89.3 percent, respectively.
Statistical analyses
Unconditional logistic regression models were fitted to individual data. Associations between male circumcision and chlamydia seropositivity were estimated by using multivariate odds ratios and their corresponding 95 percent confidence intervals. Unless otherwise specified in this report, all models were adjusted for study, man's and woman's age, and man's and woman's lifetime number of sexual partners. Stratified analyses were performed to assess the consistency of results across strata of other key variables, including condom use and cervical HPV DNA status as determined by polymerase chain reaction-based assays, as described previously (29, 30) .
We assessed whether the association of circumcision status with woman's C. trachomatis seropositivity differed significantly according to the country in which the various studies were conducted. We did so by testing in the fully adjusted logistic regression model for an interaction term combining country and circumcision status.
To rule out the possibility that potential associations between the partner's circumcision status and female chlamydial serostatus were not due to the potential contribution of other previous sexual partners, we performed further analyses restricted to monogamous women and their only male partner. Monogamy was self-reported and was defined as including only those women declaring in the interview that they had had one and only one lifetime sexual partner (n ¼ 253).
For all analyses, a two-sided p value of less than 0.05 was considered to indicate statistical significance.
RESULTS
Study subjects
Of the 1,382 women controls enrolled in one of the five case-control studies of invasive cervical cancer, 1,029 reported having a husband or stable male partner at study entry. A total of 589 of these women (57.2 percent) agreed to participate and were interviewed. Of those, 493 (83.7 percent) provided sera, and 300 (60.9 percent) and 305 (61.9 percent) of the samples were adequately tested for C. trachomatis and C. pneumoniae serology, respectively. Overall, women controls whose chlamydial serology status could be confirmed (n ¼ 305) were similar to the women whose chlamydial serology status could not be established (n ¼ 284) with respect to age, level of education, circumcision status, cervical HPV DNA status, and variables related to sexual behavior of the couple such as age at first sexual intercourse and lifetime number of sexual partners (data not shown).
The overall prevalence of circumcision was 37.0 percent: 1.8 in Spain, 6.9 in Colombia, 7.4 in Brazil, 13.3 in Thailand, and 92.5 percent in the Philippines. Compared with uncircumcised men, circumcised men were younger and more likely to have a history of multiple sexual partners. No differences were noted with regard to other sexualbehavior characteristics such as age at first sexual intercourse, ever contact with prostitutes, genital hygiene, condom use, partner's age at first sexual intercourse, or partner's lifetime number of sexual partners (data not shown). Table 1 summarizes subjects' characteristics according to C. trachomatis serostatus. The overall prevalence of female C. trachomatis was 28.0 percent: 16.7 in Brazil, 22.4 in the Philippines, 32.1 in Spain, 35.6 in Thailand, and 55.2 in Colombia. Compared with seronegative women, seropositive women were more likely to have had two or more sexual partners, be younger at first sexual intercourse, and have a current male partner with a history of multiple sexual partners.
Male circumcision and female C. trachomatis seropositivity C. trachomatis seroprevalence was lower in women whose partners were circumcised than in women whose partners were not (figure 1). Moreover, in female partners of both circumcised and uncircumcised men, C. trachomatis seropositivity increased significantly with increasing number of sexual partners that the women had had and with increasing number of sexual partners that the men had had. In contrast, C. pneumoniae seropositivity was not significantly associated with any of these sexual-behavior indicators. Table 2 shows the multivariate odds ratios for the association between male circumcision and woman's C. trachomatis seropositivity, overall and by selected characteristics of women and their male partners. Male circumcision was strongly associated with a decrease in the risk of C. trachomatis seropositivity in female partners (odds ratio (OR) ¼ 0.18, 95 percent confidence interval (CI): 0.05, 0.58; p ¼ 0.004). Although data were scarce in Spain, Colombia, and Brazil, there was no evidence of heterogeneity of the associations with respect to study location (p ¼ 0.99). The inverse association was not substantially influenced by any of the assessed characteristics of the women or of the men except for condom use, for which the inverse association was observed among non-condom-users only. The risk reduction for C. trachomatis seropositivity linked to male circumcision was particularly strong among older women (OR ¼ 0.07, 95 percent CI: 0.01, 0.45), women with older male partners (OR ¼ 0.11, 95 percent CI: 0.01, 0.93), and women whose male partners reported having six or more lifetime female sexual partners (OR ¼ 0.10, 95 percent CI: 0.01, 0.82; p ¼ 0.03). After we excluded couples from Brazil, Colombia, and Spain, the summary odds ratio was 0.27 (95 percent CI: 0.07, 1.04), and the summary odds ratio after excluding couples from only the Philippines was 0.11 (95 percent CI: 0.01, 0.91). Further adjustment by socioeconomic indicators and/or condom use did not substantially alter the magnitude of the above associations (data not shown). In contrast, none of the odds ratio estimates for the association between circumcision and C. pneumoniae seropositivity in the female partner was statistically significant (table 3) .
DISCUSSION
This study shows that adult women with current circumcised partners are less likely than women with uncircumcised partners to be seropositive for C. trachomatis antibodies. Male circumcision was associated with an overall 82 percent reduction in the risk of C. trachomatis infection in their Table continues female partners as assessed by type-specific serologic assays after taking into account the lifetime number of sexual partners of the couple. The inverse association was consistently found in all countries considered, although estimates were far from precise in Spain, Colombia, and Brazil. The strongest protective effect was found in older women (OR ¼ 0.07), in women with older male partners (OR ¼ 0.11), and in women whose current stable partners reported multiple (six or more) lifetime sexual partners (OR ¼ 0.10). In contrast, younger women and women with a history of consistent condom use were part of the only two subgroups of couples in which circumcision was not associated with reduced C. trachomatis serodetection. Our study thus supports the possibility that, as reported for other sexually transmitted infections, male circumcision reduces the risk of transmitting C. trachomatis to the female partner. The validity of our results is supported by the use of a multicenter study with a fair sample size of couples for whom questionnaire and serologic data were complete, a common protocol, and standardized laboratory procedures to ascertain type-specific serum antibodies against C. trachomatis. The specificity of the observed MIF antibody responses was validated by the observation that C. trachomatis antibody responses, unlike those for C. pneumoniae, were clearly correlated with indicators of sexual behavior (figure 1). Furthermore, no associations were found between male circumcision and past exposure to C. pneumoniae, a nonsexually-transmitted infection, neither overall nor by any of the explored characteristics of the couples (table 3) . Little reliable data are available on the natural history of C. trachomatis antibody profiles during persistent or acute infections. The stability of antibody response to a single chlamydial infection over time is difficult to study because of the asymptomatic nature of the infection and hence the difficulty in controlling for whether or how often a person has been reinfected. Although C. trachomatis antibodies have been shown to persist for years, a loss of or a decrease in immunoglobulin G antibody titers may occur over time (31, 32) , particularly if there is no continued antigenic stimulation (33) . Nevertheless, detection of type-specific C. trachomatis antibodies is generally accepted as a measure of lifetime exposure.
To our knowledge, no studies have explored at the biologic level the mechanisms by which removal of the foreskin may reduce the risk of transmitting C. trachomatis to the partner. We speculate that a penis with a prepuce is perhaps more likely to retain infected cervicovaginal secretions for a longer duration than a penis with no prepuce, subsequently increasing the likelihood of infection to the penile urethra and transmission to the vagina during intercourse.
Our study has a number of limitations that should be considered in interpreting our findings. Since cervical samples were not available because they were used for HPV testing, we could not measure current C. trachomatis infection, a piece of information that could bolster the biologic plausibility of the association. However, to explore our study hypothesis, it is more adequate and informative to measure a woman's cumulative past exposure than just current infection. A possible consequence of using chlamydial serology as a marker of past exposure is that any given woman could have acquired a previous chlamydial infection from a sexual partner other than the one included in the study. However, analyses restricted to women reporting one lifetime sexual partner also yielded an inverse and statistically significant association (OR ¼ 0.21; table 2).
It should be noted that the inverse association we found between male circumcision and serodetection of C. trachomatis antibodies in female partners is at best indirect because 1) we did not ascertain chlamydial serum antibodies in the men themselves, and 2) we measured through serology the woman's lifetime exposure to chlamydial infections but used the circumcision status of the current partner. However, the lack of association that we found with C. pneumoniae antibodies is consistent with the modes of transmission of these two infections, bolstering the overall biologic plausibility of the protective effect and the validity of the study. Even if we had determined serum antibodies in men and had not found an inverse association between circumcision status and the man's seroprevalence, our findings for women would not be necessarily inconsistent; it is possible that male circumcision reduces the risk of transmission of the infection to the partner without reducing the risk of developing an active infection in the man himself. The fact that we could not determine chlamydial serostatus in 284 women of the 589 enrolled in the entire study might have biased our results. However, it is unlikely that male circumcision or chlamydial serostatus is related to sera availability or test adequacy. To statistically assess any evidence of selection bias, we compared subjects' characteristics according to whether they had contributed a valid serologic result, and we found no statistically relevant differences between the two groups. We conclude that it is likely that the only impact of not having tested this subgroup of women concerns reduced statistical precision but not selection bias. Concerning the former, the study achieved sufficient precision not only to detect in a statistically significant manner the hypothesized inverse association but also to rule out a small effect, because the upper limit of the confidence interval of the odds ratio estimate was 0.58.
Finally, our results may be driven by the large contribution of circumcised men from the study in the Philippines. It is possible that the observed associations were mediated by other practices or characteristics of the recruited couples in the Philippines that we were not able to identify or quantify. However, it is reassuring that the direction and statistical significance of the overall association remained virtually unchanged after we excluded the couples from the Philippines (OR ¼ 0.11, 95 percent CI: 0.01, 0.91).
We have previously shown that male circumcision may reduce the risk of penile HPV, cervical HPV, and, in women with promiscuous partners, the risk of invasive cervical cancer (16, 34) . However, one potential limitation of that study was that circumcision might be related to HPV underdetection because of inadequate penile samples from circumcised men. Since circumcision status can affect neither the availability nor the adequacy of the sera being tested for chlamydial serology, our current results further strengthen our previous findings on HPV and cervical cancer. The consistency of our results for four sexually transmitted diseases (penile HPV, cervical HPV, cervical cancer, and C. trachomatis) found in the same study provides strong support for the idea that male circumcision may indeed reduce the risk of acquisition and/or transmission of a number of sexually transmitted infections.
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